ZA787000B - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
ZA787000B
ZA787000B ZA787000A ZA787000A ZA787000B ZA 787000 B ZA787000 B ZA 787000B ZA 787000 A ZA787000 A ZA 787000A ZA 787000 A ZA787000 A ZA 787000A ZA 787000 B ZA787000 B ZA 787000B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
ZA787000A
Other languages
English (en)
Inventor
S Gayst
D Harden
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA787000B publication Critical patent/ZA787000B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
ZA787000A 1978-02-06 1978-12-14 Pharmaceutical formulation ZA787000B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4669/78A GB1601833A (en) 1978-02-06 1978-02-06 Antacid formulation

Publications (1)

Publication Number Publication Date
ZA787000B true ZA787000B (en) 1980-07-30

Family

ID=9781560

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA787000A ZA787000B (en) 1978-02-06 1978-12-14 Pharmaceutical formulation

Country Status (10)

Country Link
EP (1) EP0003589B1 (fr)
JP (1) JPS54119022A (fr)
AU (1) AU525122B2 (fr)
CA (1) CA1117418A (fr)
DE (1) DE2966882D1 (fr)
GB (1) GB1601833A (fr)
IE (1) IE47811B1 (fr)
IT (1) IT1115787B (fr)
NZ (1) NZ189575A (fr)
ZA (1) ZA787000B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
EP0181966A1 (fr) * 1984-11-13 1986-05-28 Gist-Brocades N.V. Comprimés dispersibles enrobés par compression
JPH0830005B2 (ja) * 1985-09-25 1996-03-27 ゲルゲリイ、ゲルハルト 崩壊性錠剤とその製造方法
GB2201594B (en) * 1986-06-24 1991-02-13 Istvan Racz Production of acid binding pharmaceutical preparations
HU196711B (en) * 1986-06-24 1989-01-30 Istvan Racz Process for producing long-acting, gastric acid neutralizing pharmaceutics with high acid-binding capacity and increased bioavailability
ATE73328T1 (de) * 1987-05-08 1992-03-15 Smith Kline French Lab Pharmazeutische zusammensetzungen.
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
EP0349103B1 (fr) * 1988-05-04 1992-11-25 Smith Kline & French Laboratories Limited Comprimé à mâcher
US5275823A (en) * 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
ATE133068T1 (de) * 1991-01-30 1996-02-15 Wellcome Found Wasserlösliche tabletten
FR2699074B1 (fr) * 1992-12-11 1995-03-03 Georges Grimberg Procédé d'obtention d'un médicament se présentant sous la forme d'un produit comprimé pouvant être avalé, sucé, croqué, délité.
JPH08507775A (ja) * 1993-03-16 1996-08-20 ジネポス・アクチェンゲゼルシャフト 放出制御性のアルミニウム含有医薬製剤
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
EA024050B1 (ru) 2010-04-23 2016-08-31 С-БИОТЕК ХОЛДИНГ АпС Твердая фармацевтическая композиция для нейтрализации желудочной кислоты

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2550489A (en) * 1948-09-21 1951-04-24 Nat Drug Co Ulcer therapy composition
US2581035A (en) * 1949-03-26 1952-01-01 Nat Drug Co Anion exchange resin antacid
US2912358A (en) * 1955-11-02 1959-11-10 Bristol Myers Co Antacid preparations containing acrylic acid polymers and magnesium antacids
GB1057940A (en) * 1963-10-08 1967-02-08 Jean Paul Marc Raudnitz Improvements in and relating to the preparation of pharmacentical compositions comprising orally active mineral medicaments
GB1269987A (en) * 1968-04-18 1972-04-12 Garland Richard Brown Antacid composition
GB1460302A (en) * 1973-05-23 1977-01-06 Wellcome Found Tablet formulation
GB1499672A (en) * 1974-02-14 1978-02-01 Wellcome Found Tablet formulation
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation

Also Published As

Publication number Publication date
AU4392179A (en) 1979-08-16
AU525122B2 (en) 1982-10-21
NZ189575A (en) 1981-05-29
IT7947892A0 (it) 1979-02-05
EP0003589A3 (en) 1979-09-05
EP0003589A2 (fr) 1979-08-22
IE790209L (en) 1979-08-06
GB1601833A (en) 1981-11-04
JPS54119022A (en) 1979-09-14
CA1117418A (fr) 1982-02-02
DE2966882D1 (en) 1984-05-17
EP0003589B1 (fr) 1984-04-11
IE47811B1 (en) 1984-06-27
IT1115787B (it) 1986-02-03

Similar Documents

Publication Publication Date Title
GB2039738B (en) Inflammation - preventing pharmaceutical composition
ZA793542B (en) Pharmaceutical preparations
DE3172028D1 (en) Pharmaceutical formulation
ZA795039B (en) Pharmaceutical preparations
ZA796549B (en) New pharmaceutical preparations
ZA787000B (en) Pharmaceutical formulation
GB2020655B (en) Pharmaceutical compounds
ZA804196B (en) Pharmaceutical formulations
NZ189684A (en) Substituted 2-phenylimino-imidazolidines pharmaceutical compositions
IL56577A0 (en) Pharmaceutical compositions comprising certain pyrrolidinederivatives
ZA79395B (en) Pharmaceutical formulations
NZ190810A (en) 1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
ZA793923B (en) Medicinal formulation
GB2034587B (en) Pharmaceutical compositions
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
GB2039218B (en) Pharmaceutical compositions
GB2031727B (en) Pharmaceutical compositions
JPS54154516A (en) Pharmaceutical composition
JPS5527168A (en) Drug composition
ZA793928B (en) Medicinal formulation
ZA794484B (en) Pharmaceutical compositions
ZA817572B (en) Pharmaceutical formulation
ZA791032B (en) Pharmaceutical compositions
GB2028660B (en) Administration set
NZ190958A (en) 2-phenylamino-2-imidazoline derivatives pharmaceutical compositions